In vitro comparison of nebulised budesonide (Pulmicort Respules®) and beclomethasone dipropionate (Clenil® per Aerosol)

Pulmonary Pharmacology and Therapeutics

Volumn 18, Issue 2, 2005, Pages 151-153

  Vaghi, A ^a   Berg, E ^b   Liljedahl, S ^b   Svensson, J O ^b  

^a RHO HOSPITAL   (Italy)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE;

AEROSOL; ARTICLE; DRUG DOSAGE FORM; NEBULIZATION; NEBULIZER; PARTICLE SIZE; PRIORITY JOURNAL;

BECLOMETHASONE; BUDESONIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOCORTICOIDS; HUMANS; LUNG; MICROSCOPY, ELECTRON, SCANNING; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE;

EID: 11844261468     PISSN: 10945539     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pupt.2004.10.004     Document Type: Article

References (5)

1. Global Initiative for Asthma. Workshop report: strategy for asthma management and prevention (updated 2002). Scientific information and recommendations for asthma programs. NIH publication No. 02-3659. Bethesda, MD: National Institutes for Health; 2002.
2. L. Thorsson, S. Edsbäcker, and T.B. Conradson Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered dose inhaler (pMDI) Eur Respir J 7 1994 1839 1844
3. European Standard, E N 13544-1 Respiratory therapy equipment, part 1: nebulizing systems and their components 2001 European Committee for Standardization Brussels, Belgium
4. R. Pauwels, S. Newman, and L. Borgström Airway deposition and airway effects of antiasthma drugs delivered from metered-dose inhalers Eur Respir J 10 1997 2127 2138
5. R. Beasley, P.J. Sterk, H.A.M. Kerstjens, and M. Decramer Comparative studies of inhaled corticosteroids in asthma Eur Respir J 17 2001 579 580